Typical patient populations susceptible to infection due to coexisting drug treatment
- Oncology/Haematology Patients – chemotherapy
- Organ Transplant recipients – Immunosuppressants
- Patients with chronic inflammatory conditions e.g. rheumatoid arthritis, chronic nephritis – steroids, Immunomodulators